A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report.
Evelien MoorkensTeresa Barcina LacostaDalia DawoudAndrás InotaiManthan JanodiaChia Jie TanKa Keat LimNishtha KhatriCatarina Lopes PereiraSteven SimoensPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
There is a need to gather further insights in the methodology of value assessment for biosimilars, and health technology assessment agencies need to develop more elaborate guidance on biosimilar value assessment in specific circumstances.
Keyphrases